![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CSTF2T | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Cstf2t (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CSTF2T mRNA | CTD | PMID:36331819 | CSTF2T | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Cstf2t (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSTF2T mRNA | CTD | PMID:22206623 | CSTF2T | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Cstf2t (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CSTF2T mRNA | CTD | PMID:22206623 | CSTF2T | Human | 1,3-dinitrobenzene | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | 3-dinitrobenzene results in decreased expression of CSTF2T mRNA | CTD | PMID:21983209 | CSTF2T | Human | 17alpha-ethynylestradiol | increases expression | ISO | Cstf2t (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of CSTF2T mRNA | CTD | PMID:17942748 | CSTF2T | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Cstf2t (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSTF2T mRNA | CTD | PMID:17942748 | CSTF2T | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cstf2t (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSTF2T mRNA | CTD | PMID:17942748 | CSTF2T | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CSTF2T mRNA | CTD | PMID:33387578 | CSTF2T | Human | 3',5'-cyclic UMP | affects binding | EXP | | 6480464 | CSTF2T protein binds to cyclic 3' and 5'-uridine monophosphate | CTD | PMID:30528433 | CSTF2T | Human | aflatoxin B1 | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in decreased expression of CSTF2T mRNA | CTD | PMID:33354967 | CSTF2T | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CSTF2T mRNA | CTD | PMID:21934132 | CSTF2T | Human | amitrole | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of CSTF2T mRNA | CTD | PMID:38685447 | CSTF2T | Human | bis(2-ethylhexyl) phthalate | increases expression | ISO | Cstf2t (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of CSTF2T mRNA | CTD | PMID:34319233 | CSTF2T | Human | bisphenol A | increases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of CSTF2T mRNA | CTD | PMID:25181051 and PMID:33296240 | CSTF2T | Human | C60 fullerene | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of CSTF2T mRNA | CTD | PMID:19167457 | CSTF2T | Human | cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of CSTF2T mRNA | CTD | PMID:24376830 | CSTF2T | Human | cadmium dichloride | increases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of CSTF2T mRNA | CTD | PMID:33453195 | CSTF2T | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CSTF2T mRNA | CTD | PMID:19549813 | CSTF2T | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CSTF2T mRNA | CTD | PMID:25562108 | CSTF2T | Human | DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of CSTF2T mRNA | CTD | PMID:38568856 | CSTF2T | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | CSTF2T | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CSTF2T mRNA | CTD | PMID:29803840 | CSTF2T | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CSTF2T protein | CTD | PMID:23301498 | CSTF2T | Human | fipronil | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | fipronil results in decreased expression of CSTF2T mRNA | CTD | PMID:23962444 | CSTF2T | Human | folic acid | multiple interactions | ISO | Cstf2t (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSTF2T mRNA | CTD | PMID:22206623 | CSTF2T | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of CSTF2T protein | CTD | PMID:37730182 | CSTF2T | Human | gentamycin | increases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CSTF2T mRNA | CTD | PMID:22061828 | CSTF2T | Human | inulin | multiple interactions | ISO | Cstf2t (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CSTF2T mRNA | CTD | PMID:36331819 | CSTF2T | Human | iron atom | decreases expression | EXP | | 6480464 | Iron deficiency results in decreased expression of CSTF2T mRNA | CTD | PMID:20368581 | CSTF2T | Human | iron(0) | decreases expression | EXP | | 6480464 | Iron deficiency results in decreased expression of CSTF2T mRNA | CTD | PMID:20368581 | CSTF2T | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of CSTF2T protein | CTD | PMID:32959892 | CSTF2T | Human | manganese atom | multiple interactions | EXP | | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in increased expression of CSTF2T mRNA | CTD | PMID:39836092 | CSTF2T | Human | manganese(0) | multiple interactions | EXP | | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in increased expression of CSTF2T mRNA | CTD | PMID:39836092 | CSTF2T | Human | manganese(II) chloride | multiple interactions | EXP | | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in increased expression of CSTF2T mRNA | CTD | PMID:39836092 | CSTF2T | Human | methapyrilene | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Methapyrilene results in decreased expression of CSTF2T mRNA | CTD | PMID:30467583 | CSTF2T | Human | methotrexate | affects expression | ISO | Cstf2t (Mus musculus) | 6480464 | Methotrexate affects the expression of CSTF2T mRNA | CTD | PMID:18502557 | CSTF2T | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of CSTF2T mRNA | CTD | PMID:28001369 | CSTF2T | Human | nitrates | multiple interactions | ISO | Cstf2t (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CSTF2T mRNA | CTD | PMID:35964746 | CSTF2T | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of CSTF2T mRNA | CTD | PMID:35430440 | CSTF2T | Human | paracetamol | affects expression | ISO | Cstf2t (Mus musculus) | 6480464 | Acetaminophen affects the expression of CSTF2T mRNA | CTD | PMID:17562736 | CSTF2T | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CSTF2T mRNA | CTD | PMID:21420995 | CSTF2T | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cstf2t (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CSTF2T mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CSTF2T mRNA | CTD | PMID:36331819 | CSTF2T | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of CSTF2T mRNA | CTD | PMID:26272509 | CSTF2T | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSTF2T mRNA | CTD | PMID:27188386 | CSTF2T | Human | pirinixic acid | decreases expression | ISO | Cstf2t (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of CSTF2T mRNA | CTD | PMID:18445702 | CSTF2T | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | CSTF2T | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of CSTF2T mRNA | CTD | PMID:23806026 | CSTF2T | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of CSTF2T mRNA | CTD | PMID:38568856 | CSTF2T | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of CSTF2T mRNA | CTD | PMID:31533062 | CSTF2T | Human | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of CSTF2T mRNA | CTD | PMID:31758290 | CSTF2T | Human | thioacetamide | affects methylation | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Thioacetamide affects the methylation of CSTF2T promoter | CTD | PMID:25151969 | CSTF2T | Human | thioacetamide | affects expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Thioacetamide affects the expression of CSTF2T mRNA | CTD | PMID:25151969 | CSTF2T | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of CSTF2T mRNA | CTD | PMID:38568856 | CSTF2T | Human | topotecan | affects response to substance | EXP | | 6480464 | CSTF2T protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | CSTF2T | Human | trichloroethene | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of CSTF2T mRNA | CTD | PMID:33387578 | CSTF2T | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of CSTF2T mRNA | CTD | PMID:24935251 and PMID:26272509 | CSTF2T | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSTF2T mRNA | CTD | PMID:27188386 | CSTF2T | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of CSTF2T mRNA | CTD | PMID:37042841 | CSTF2T | Human | troglitazone | decreases expression | ISO | Cstf2t (Mus musculus) | 6480464 | troglitazone results in decreased expression of CSTF2T mRNA | CTD | PMID:28973697 | CSTF2T | Human | trovafloxacin | increases expression | ISO | Cstf2t (Mus musculus) | 6480464 | trovafloxacin results in increased expression of CSTF2T mRNA | CTD | PMID:35537566 | CSTF2T | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of CSTF2T mRNA | CTD | PMID:28818685 | CSTF2T | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CSTF2T mRNA | CTD | PMID:25979313 | CSTF2T | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CSTF2T mRNA | CTD | PMID:23179753 more ... | CSTF2T | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSTF2T mRNA | CTD | PMID:27188386 | CSTF2T | Human | vitamin D | affects expression | EXP | | 6480464 | Vitamin D affects the expression of CSTF2T mRNA | CTD | PMID:20368581 | |